• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Medicines Co/The

+ Add to Watchlist

MDCO:US

26.2700 USD 0.6600 2.58%

As of 14:37:59 ET on 09/02/2014.

Company Profile for Medicines Co/The (MDCO)

The Medicines Company develops products that improve specialized care. The Company markets Angiomax, an anticoagulant approved in the United States and other countries for use in patients undergoing coronary angioplasty procedures.

Contact Information

Medicines Co/The

8 Sylvan Way
Parsippany, NJ 07054
United States
Phone: 1-973-290-6000

Key Executives for Medicines Co/The (MDCO)

Clive A MeanwellChairman/CEOGlenn P SblendorioPresident/CFO
Victoria KusiakExec VP/Chief Integrity OfcrBrent FurseExec VP/Chief Customer Officer
Cornelis Heiman "Cees"Exec VP/Chief Innovation OfcrWilliam B O'ConnorSenior VP/Chief Acctg Officer
Stephen M RodinSenior VP/Secy/General CounselNeera D RavindranVP:Investor Relations

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil